Arecor Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AREC?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	82,800	0.219%
Individual Insiders	3,000,789	7.95%
Public Companies	3,010,813	7.97%
VC/PE Firms	6,450,372	17.1%
General Public	10,943,006	29%
Institutions	14,268,821	37.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.3%.

Top Shareholders

Top 25 shareholders own 67.58% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.7%	BGF Investment Management Ltd.	4,046,968	UK£2.8m	0%	0.76%
7.76%	Unilever PLC	2,929,926	UK£2.0m	0%	no data
6.37%	Calculus Capital Limited	2,403,404	UK£1.7m	-0.04%	35.88%
5.19%	Lombard Odier Asset Management (Europe) Ltd.	1,961,127	UK£1.4m	6.23%	0.03%
4.21%	Oxford Technology Management Limited	1,587,776	UK£1.1m	0%	100.0%
4.15%	Stewart Newton	1,565,408	UK£1.1m	11.2%	no data
3.78%	Downing Ventures	1,426,931	UK£991.7k	617%	1.33%
3.58%	Chelverton Asset Management Limited	1,350,548	UK£938.6k	-5.22%	0.09%
3.18%	Unicorn Asset Management Ltd.	1,198,828	UK£833.2k	0%	0.14%
2.95%	Albion Capital Group LLP	1,113,724	UK£774.0k	0%	16.28%
2.89%	The Wood Family Trust, Endowment Arm	1,091,201	UK£758.4k	0%	100.0%
2.3%	Sarah Howell	867,738	UK£603.1k	0%	no data
1.89%	Amati Global Investors Ltd.	714,019	UK£496.2k	0%	0.11%
1.63%	Canaccord Genuity Asset Management Limited	617,142	UK£428.9k	0.29%	0.02%
1.04%	Seneca Partners Limited	394,029	UK£273.8k	0%	0.03%
0.93%	Mole Valley Asset Management Ltd	351,820	UK£244.5k	44.2%	1.04%
0.81%	Foresight Group LLP	306,955	UK£213.3k	-80%	0.06%
0.71%	Lansdowne Partners Limited	269,897	UK£187.6k	-51.4%	0.01%
0.59%	Andrew John Richards	223,834	UK£155.6k	0%	no data
0.59%	Rathbones Investment Management Limited	223,069	UK£155.0k	-1.88%	no data
0.5%	Canaccord Genuity Wealth (International) Ltd.	188,072	UK£130.7k	-4.7%	no data
0.48%	Alan Smith	181,765	UK£126.3k	0%	no data
0.45%	Hedley & Company Stockbrokers Ltd, Asset Management Arm	169,976	UK£118.1k	0%	0.1%
0.44%	Charles Stanley & Co. Ltd, Asset Management Arm	166,889	UK£116.0k	39.9%	no data
0.44%	Panmure Gordon & Co. Ltd., Asset Management Arm	165,479	UK£115.0k	143%	0.23%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 22:56
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arecor Therapeutics plc is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Dr Julie	Panmure Liberum
Julie Simmonds	Panmure Liberum
Julie Simmonds	Panmure Liberum Historic (Panmure Gordon)